CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Plasma rich platelet injection +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03112330
NCT03112330N/ACompleted
CompareCT.gov

A Single-center, Non-randomized, Open, Single-arm Confirmatory Clinical Study to Evaluate the Safety and Efficacy of Platelet Rich Plasma Injection for Patients With Atrophic Rhinitis

Seoul St. Mary's Hospital·interventional·Posted Apr 13, 2017·Updated Apr 4, 2019

In Brief

A clinical study evaluating Plasma rich platelet injection and Saline nasal spray for Atrophic Rhinitis. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The goal of the suggested research is to develop a treatment option using platelet rich plasma injection for regeneration of atropic nasal mucosa. Specific aims of the suggested research is to (1) access the effect of platelet rich plasma in the patients with atropic rhinitis . Moreover, we will (2) compare the conservative treatments including saline nasal irrigation or saline nasal spray.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrophic Rhinitis
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 13, 2017
Enrollment StartJun 8, 2017
Primary CompletionApr 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.2 years ago

Interventions

Plasma rich platelet injectiondevice

Plasma rich platelet injection with 26-gauge needle and 2cc syringe on inferior turbinate mucosa

Saline nasal spraydevice

two puffs of isotonic saline nasal spray twice daily